Marshall Wace, LLP Ab Cellera Biologics Inc. Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $2.43 Million - $3.73 Million	-256,797 Reduced 72.46%	97,600 $988,000
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $1.47 Million - $2.18 Million	-159,313 Reduced 31.01%	354,397 $3.51 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $2.94 Million - $5.47 Million	513,710 New	513,710 $5.47 Million
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $4.39 Million - $5.99 Million	-338,120 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $962,888 - $1.38 Million	64,841 Added 23.73%	338,120 $6.78 Million
Q2 2021 Aug 13, 2021	BUY	$20.19 - $34.17 $4.5 Million - $7.61 Million	222,638 Added 439.64%	273,279 $6.01 Million
Q1 2021 May 17, 2021	SELL	$23.29 - $53.2 $10.8 Million - $24.6 Million	-461,769 Reduced 90.12%	50,641 $1.72 Million
Q4 2020 Feb 16, 2021	BUY	$39.0 - $58.9 $20 Million - $30.2 Million	512,410 New	512,410 $20.6 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.